Detecting signs of Fabry and Pompe disease in UK clinical data
Volv, working with Sanofi, Optimum Patient Care, and collaborating with a specialist Consultant Clinician, is performing work to build algorithms in the UK which are aimed at finding ways to better identify people living with Fabry or Pompe disease.
This novel and innovative methodology, inTrigue, is highlighting ways in which we can be much more precise in detecting people living with either disease much earlier.